Skip to main content

Microneedle Patch Might Restore Hair Growth After Alopecia

Medically reviewed by Carmen Pope, BPharm. Last updated on June 10, 2024.

By Carole Tanzer Miller HealthDay Reporter

MONDAY, June 10, 2024 -- Researchers have developed a novel way to promote hair growth in people who have the autoimmune disease alopecia areata.

It's a skin patch that delivers immune-system controllers through an array of tiny needles.

In alopecia, the body's own T-cells mistakenly attack hair follicles. The experimental treatment strategy uses a patch to deliver specialized cells called T-cell regulators, or Tregs for short, directly to balding spots. The aim is to thwart the unwanted immune system attack and halt hair loss.

Current immunosuppressants used to treat alopecia target both T-cells as well as the Tregs.

"Our patches enable local delivery of biologics, which, instead of suppressing the immune system, promote regulatory T-cells in the skin," explained co-corresponding author Natalie Artzi, a researcher at Brigham and Women's Hospital in Boston. "This restores immune balance and resolves the T-cell attack on hair follicles, offering a potential long-term solution without compromising the immune system's ability to defend against infections and malignancies."

In autoimmune conditions like alopecia, Tregs fall short in protecting hair follicles. Current treatments, which suppress the immune system response, fail to address the underlying issue and increase the odds that hair loss will return once treatment stops. They also put patients at risk for infection and malignancies.

In the new approach, a microneedle patch is used to deliver drugs through the skin without stimulating pain receptors located deeper within it.

"While topical therapy often fails to penetrate the skin's outer layer, our patches improve the local delivery of biologics to the deeper layers of diseased skin and reprogram the immune system to generate tolerance at the site of antigen encounter," co-corresponding author Dr. Jamil Azzi, an immunologist at Brigham and Women's, said in a hospital news release.

The microneedle patch is still being refined and tested and is not yet ready for clinical use. Researchers, who reported on the patch recently in the journal Advance Materials, are looking at ways it might be deployed to treat other autoimmune skin diseases, such as vitiligo and psoriasis.

"This targeted approach holds great potential for improving treatment outcomes and reducing the burden of autoimmune and immune-mediated diseases on patients' lives," Artzi said.

Sources

  • Brigham and Women's Hospital, news release, June 6, 2024

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted June 2024

Read this next

FDA Warns of Unapproved Hair-Loss Product Linked to Side Effects

THURSDAY, April 24, 2025 — A quick spray of medication might seem like an easy way to get thicker hair, but some people say one sold online has left them battling sexual...

Rare Hair Loss Condition Can Be Treated With Low Doses Of Antibiotic Doxycycline

WEDNESDAY, March 19, 2025 -- Lower doses of a common antibiotic can curb hair loss caused by a rare skin condition, a new study says. The antibiotic doxycycline is commonly used...

Women With Cancer Can Safely Use Rogaine to Curb Hair Loss

WEDNESDAY, Dec. 11, 2024 -- Women worried about losing their locks during chemotherapy can safely take hair-loss drugs during breast cancer care, a new study says. Minoxidil -...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.